The Increasing Cost of Truvada (PrEP) is Leading to an Increase in the Contraction of HIV A Policy Alternative
Article Sidebar
Main Article Content
Abstract
There is a growing population of individuals who cannot afford the prevention treatment, PrEP, for HIV infection. Those insured with private health care are able to afford this treatment as it is taken from deductibles. Public insurance is at no help to these individuals due to not having certain plans and policies that help them afford this life saving treatment. Policy alternatives are needed to give those who cannot afford PrEP a better way of life, and needed, to emphasize the fact that healthcare is a right and shouldn't be infringed upon with the cost of prescription medication. This policy alternative takes a look at different policy reccomendations to change the way public insurance holders are able to receive this treatment. Data was collected through the U.S Census Bureau, the U.S Congressional Libray and the Center for Disease Control.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Student authors waive FERPA rights for only the publication of the author submitted works.
Specifically: Students of Indiana University East voluntarily agree to submit their own works to The Journal of Student Research at Indiana University East, with full understanding of FERPA rights and in recognition that for this one, specific instance they understand that The Journal of Student Research at Indiana University East is Public and Open Access. Additionally, the Journal is viewable via the Internet and searchable via Indiana University, Google, and Google-Scholar search engines.
References
CDC. Estimated HIV incidence and prevalence in the United States, 2014-2018. HIV surveillance Supplemental Report 2020; 25(No. 1).
Furukawa NW, Zhu W, Huang Y-LA, Shrestha RK, Hoover KW. National trends in drug payments for HIV preexposure prophylaxis in the United States, 2014 to 2018. Ann Intern Med. Published online September 8, 2020. doi:10.7326/M20-0786
APA. Effect of Not Having Treatment for Displaced HIV Prevention Patients. American Psychological Association 2020
U.S. Attorney’s Office, McDermott Will & Energy. Reverse False Claims and 60-Day rule for Medicare and Medicaid. 2016
Coutinho B. Prasad R. Emtricitabine/Tenofovir (Truvada) for HIV Prophylaxis. Am Fam Physician. Published online October 15, 2013; 88(8):535-540